Escalated doses of lomitapide (5–10 mg/day; orally) with or without ezetimibe have been tested in patients with moderate hypercholesterolemia for a period of 12 weeks. The results indicated a ...

No writing assistance was utilized in the production of this manuscript. Homozygous familial hypercholesterolemia is a rare but significant cause of early-onset coronary heart disease. Early ...

Familial Hypercholesterolemia "The justly celebrated unraveling of the LDL receptor pathway revealed that mutations in a ...

High "bad" cholesterol, or hypercholesterolemia, affects about 10% of adults in the United States and about 7% of youth, ...

NYC Health + Hospitals/Queens held a ribbon-cutting ceremony last month to celebrate the launch of its new Weight Management ...

Heterozygous familial hypercholesterolemia was associated with increased type 2 diabetes risk, especially among those with obesity and statin use.

Managing DME/DR Lifestyle changes: Strict control of diabetes, hypertension, and hypercholesterolemia, along with dietary ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and ...